Selected article for: "liver disease and physical activity"

Author: Tincopa, Monica A.; Lyden, Angela; Wong, Jane; Jackson, Elizabeth A.; Richardson, Caroline; Lok, Anna S.
Title: Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease
  • Cord-id: 3sdgj9d3
  • Document date: 2021_5_3
  • ID: 3sdgj9d3
    Snippet: BACKGROUND AND AIMS: Lifestyle modification is the main treatment for nonalcoholic fatty liver disease (NAFLD), but remains challenging to implement. The aim of this pilot was to assess the acceptability and feasibility of a mobile-technology based lifestyle program for NAFLD patients. METHODS: We enrolled adult patients with NAFLD in a 6-month mobile-technology based program where participants received a FitBit with weekly tailored step count goals and nutritional assessments. Anthropometrics,
    Document: BACKGROUND AND AIMS: Lifestyle modification is the main treatment for nonalcoholic fatty liver disease (NAFLD), but remains challenging to implement. The aim of this pilot was to assess the acceptability and feasibility of a mobile-technology based lifestyle program for NAFLD patients. METHODS: We enrolled adult patients with NAFLD in a 6-month mobile-technology based program where participants received a FitBit with weekly tailored step count goals and nutritional assessments. Anthropometrics, hepatic and metabolic parameters, Fibroscan, physical function and activity, and health-related quality of life measures were obtained at enrollment and month 6. Semi-structured exit interviews were conducted to assess patient’s experience with the program. RESULTS: 40 (63%) eligible patients were enrolled. Median age was 52.5 with 53% males, 93% whites, 43% with diabetes and median BMI 33.9. On baseline Fibroscan, 59% had F0-2 fibrosis and 70% had moderate-severe steatosis. 33 patients completed the study. Median percentage of days with valid FitBit data collection was 91. 4 patients increased and maintained, 19 maintained, and 8 increased but subsequently returned to baseline weekly step count. 59% of patients reported Fitbit was easy to use and 66% felt step count feedback motivated them to increase their activity. Roughly 50% of patients had reduction in weight, triglycerides and Fibroscan liver stiffness, and 75% had improvement in controlled attenuation parameter and physical function. CONCLUSIONS: A 6-month mobile-technology based pilot lifestyle intervention was feasible and acceptable to NAFLD patients. The program promoted physical activity and was associated with improvement in clinical parameters in some patients.

    Search related documents:
    Co phrase search for related documents
    • acceptability feasibility and activity intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acceptability feasibility and activity level: 1
    • acceptability feasibility and adherence rate: 1, 2
    • acceptability feasibility and liver disease: 1, 2
    • acceptable intervention and activity increase: 1, 2, 3
    • acceptable intervention and activity intervention: 1, 2, 3, 4
    • acceptable intervention and activity level: 1
    • activity increase and adherence rate: 1, 2
    • activity increase and liver disease: 1, 2
    • activity intervention and adherence rate: 1, 2
    • activity intervention and liver biopsy: 1
    • activity intervention and liver disease: 1
    • activity level and liver disease: 1, 2, 3, 4, 5
    • activity level and liver stiffness: 1
    • adherence rate and liver disease: 1
    • adherence rate and liver disease cause: 1